SCHEMBL21768045

SCHEMBL21768045

COCCOc1cccc(NC(=O)c2ccc(OCC(=CF)CNC(=O)OC(C)(C)C)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPK1 P28482 1/20 0.46
PKM P14618 2/20 0.45
HTT P42858 1/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 4/20 0.44
LMNA P02545 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
MAPK14 Q16539 1/20 0.43
MEN1 O00255 2/20 0.43
NR1H4 Q96RI1 3/20 0.43
AOC3 Q16853 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21768044 1.00 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL21780050 0.86 AOC3 (0.49) ALDH1A1MAPK1SMN1; SMN2KMT2ANPC1
SCHEMBL21780053 0.84 AOC3 (0.48) ALDH1A1CYP1A2MAPTSMN1; SMN2KMT2A
SCHEMBL21780059 0.84 MAOB (0.56) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL21845069 0.84 MAOB (0.56) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL21768161 0.81 MAOB (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL21768031 0.81 MAOB (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL30089473 0.81 MAOB (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL21768026 0.81 MAOB (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL30089445 0.81 MAOB (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110352188-B Fluoroallylamine derivatives and use thereof 四川科伦博泰生物医药股份有限公司 2022-11-29 CN disclosed
US-20200087248-A1 Fluoroallylamine Derivative And Use Thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-03-19 US disclosed
EP-3617186-A1 FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087248-A1 Fluoroallylamine Derivative And Use Thereof VAPB, VAPA, SLC28A1 ALDH1A1 71/4885CYP1A2 317/4885CYP3A4 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.